Ambiq and ThinkAR Disrupt the AR Glasses Industry with the AiLens
Notified -
Globe Newswire7-01-2025, 21:15
Biosidus Announces Promising Interim Results from Phase III Study on Agalsidase Beta for Fabry Disease 17-04-2025, 03:44
7-01-2025, 21:15
